These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19142116)

  • 1. Olanzapine-induced "restless arms syndrome".
    Konstantakopoulos G; Oulis P; Michalopoulou PG; Papadimitriou GN
    J Clin Psychopharmacol; 2009 Feb; 29(1):89-90. PubMed ID: 19142116
    [No Abstract]   [Full Text] [Related]  

  • 2. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine.
    Kraus T; Schuld A; Pollmächer T
    J Clin Psychopharmacol; 1999 Oct; 19(5):478-9. PubMed ID: 10505594
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
    Henderson DC; Copeland PM; Daley TB; Borba CP; Cather C; Nguyen DD; Louie PM; Evins AE; Freudenreich O; Hayden D; Goff DC
    Am J Psychiatry; 2005 May; 162(5):954-62. PubMed ID: 15863798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine-associated pica in a schizophrenia patient.
    Huang JH; Shiah IS; Lee WK; Tzang RF; Chang KJ
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):444. PubMed ID: 20653915
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine vs haloperidol for treatment of schizophrenia.
    Glazer WM
    JAMA; 2004 Mar; 291(9):1064-5; author reply 1065-6. PubMed ID: 14996766
    [No Abstract]   [Full Text] [Related]  

  • 6. Late-onset cholestatic hepatitis induced by olanzapine in a patient with schizophrenia.
    Hung CC; Wei IH; Huang CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1574-5. PubMed ID: 19766687
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine pamoate - blockbuster or damp squib?
    Taylor DM
    Int J Clin Pract; 2009 Apr; 63(4):540-1. PubMed ID: 19335703
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
    McEvoy JP; Lieberman JA; Perkins DO; Hamer RM; Gu H; Lazarus A; Sweitzer D; Olexy C; Weiden P; Strakowski SD
    Am J Psychiatry; 2007 Jul; 164(7):1050-60. PubMed ID: 17606657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine-induced restless leg syndrome: a case report and review of literature.
    Basu A; Kundu S; Khurana H
    Indian J Pharmacol; 2014; 46(4):450-2. PubMed ID: 25097291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible olanzapine-induced hepatotoxicity in a young Chinese patient.
    Lui SY; Tso S; Lam M; Cheung EF
    Hong Kong Med J; 2009 Oct; 15(5):394-6. PubMed ID: 19801701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine vs haloperidol for treatment of schizophrenia.
    Amin M; Shukla VS
    JAMA; 2004 Mar; 291(9):1065; author reply 1065-6. PubMed ID: 14996767
    [No Abstract]   [Full Text] [Related]  

  • 12. [Olanzapine-associated neuroleptic malignant syndrome. A case report and favorable response to risperidone].
    López-Torres E; Cobo I; Lucena MI
    Actas Esp Psiquiatr; 2007; 35(2):145-6. PubMed ID: 17401786
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine-induced tardive dystonia successfully treated by tetrabenazine.
    Rauchverger B; Isakov V; Jabarin M
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):484-5. PubMed ID: 18070868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Post-injection syndrome and olanzapine pamoate: A severe case report].
    Descusse A; Chebili S; Artiges E
    Encephale; 2017 Aug; 43(4):405. PubMed ID: 27349579
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acquired stuttering in a psychotic patient].
    Klein Hofmeijer-Sevink M; van Eijk ZJ; van der Zwaard R
    Tijdschr Psychiatr; 2009; 51(1):53-7. PubMed ID: 19194846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine.
    Kang SG; Lee HJ; Kim L
    J Psychopharmacol; 2009 Jul; 23(5):597-601. PubMed ID: 18562412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine treatment of eight adolescent patients with psychosis.
    Ercan ES; Kutlu A; Varan A; Cikoğlu S; Coşkunol H; Bayraktar E
    Hum Psychopharmacol; 2004 Jan; 19(1):53-6. PubMed ID: 14716713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study.
    Novick D; Haro JM; Suarez D; Marques-Teixeira J; Naber D
    Int Clin Psychopharmacol; 2008 Jul; 23(4):203-8. PubMed ID: 18545058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal effect of olanzapine on fasting serum lipids: a randomized, prospective, 4-month study.
    Kinon BJ; Liu-Seifert H; Ahl J; Ahmed S; Baker RW
    Ann N Y Acad Sci; 2004 Dec; 1032():295-6. PubMed ID: 15677433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
    Chen CH; Huang MC; Lu ML
    J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.